Health News Editor
The Rise of Concierge Medicine: Exploring the High Costs for Patients
Money has the power to make life easier in many ways. From first-class airline tickets to VIP theme park passes, having extra cash can streamline your experiences. But what if you could use that...
CAR-T Therapy Shows Promise in Treating Aggressive Brain Tumors in Young Patients
Michelle Monje-Deisseroth, a medical student about 20 years ago, treated patients with a type of brain tumor called diffuse intrinsic pontine gliomas, or DIPG. These tumors are difficult to treat because they wrap around...
Reaction to Trump’s selection of RFK Jr. for HHS leadership
Leaders in the biopharma world and scientific community were taken aback by the news that President-elect Donald Trump has chosen Robert F. Kennedy Jr. to lead the Department of Health and Human Services. This...
Global Measles Cases Increase by 20% in 2023: New Report
Measles vaccination coverage has not yet returned to pre-Covid levels globally, leading to a 20% increase in measles cases in 2023 compared to the previous year, as per a recent report from the World...
Understanding Guttate Psoriasis in Adults: Causes, Symptoms, Treatment
Guttate psoriasis is a skin condition that can affect people of all ages, races, and genders, but it is most commonly seen in children and individuals under 30 years old. It affects both men...
Understanding Cachexia in Cancer Patients: Causes, Symptoms, and Treatment Options
Cancer cachexia is a condition that causes weakness, fatigue, and loss of muscle and fat in cancer patients. Unlike malnutrition, it cannot be reversed with nutrition support alone. It is most common in people...
Pharmalittle: GSK Leaves BIO, AbbVie Schizophrenia Drug Fails & More – Pharma News Update
Good morning, everyone, and welcome to a new week of work. We hope you had a restful weekend and are ready to dive back into the routine of online meetings and deadlines. Let's start...
Ending 23andMe’s Drug Discovery Dream: What Went Wrong?
23andMe, the genetics company that many people have been excited about, recently made a big announcement. The company has decided to stop working on creating new medicines and will be letting go of 40%...
Understanding and Addressing Cardiovascular Health Disparities: Insights from Recent Studies
The recent election results may have shifted focus away from diversity, equity, and inclusion, but new research papers emphasize the importance of addressing health disparities based on socioeconomic factors. These papers, set to be...
Navigating Sickle Cell Pain, Loss, and Survival in America
Today, I want to talk about Tammy Clemons, a woman who is navigating the challenges of living with sickle cell disease in America. Tammy's story is one of pain, loss, and survival, and it...
GSK Withdraws from BIO, Signaling Major Setback for Lobbying Group
Pharmaceutical company GSK has announced its decision to leave the Biotechnology Innovation Organization (BIO), which is the largest trade group in the biotechnology industry. This move by GSK marks a significant setback for the...
The Impact of Trump’s Return on NIH Funding and Politicization: What to Expect
After Donald Trump's election win, National Institutes of Health director Monica Bertagnolli addressed the agency's employees, emphasizing the organization's long-standing commitment to biomedical research for public health. Despite reassurances from the NIH, concerns are...